Neuburgh Advisers’s Zimmer Biomet ZBH Stock Holding History

Neuburgh Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$722K	Sell	5,416 -974	-15%	-$126K	0.02%	385
2019 Q2	$730K	Sell	6,390 -1,813	-22%	-$212K	0.02%	381
2019 Q1	$1.02M	Buy	8,203 +974	+13%	+$111K	0.03%	296
2018 Q4	$728K	Sell	7,229 -657	-8%	-$73.9K	0.03%	322
2018 Q3	$1.01M	Sell	7,886 -408	-5%	-$48.5K	0.03%	300
2018 Q2	$897K	Buy	8,294 +612	+8%	+$66.6K	0.03%	305
2018 Q1	$813K	Buy	7,682 +159	+2%	+$18.5K	0.03%	305
2017 Q4	$881K	Buy	7,523 +1,042	+16%	+$118K	0.03%	308
2017 Q3	$737K	Buy	6,481 +182	+3%	+$21K	0.03%	322
2017 Q2	$785K	Sell	6,299 -46	-0.7%	-$5.45K	0.03%	314
2017 Q1	$752K	Buy	6,345 +703	+12%	+$79.7K	0.03%	307
2016 Q4	$565K	Buy	+5,642	New	+$605K	0.03%	317

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Neuburgh Advisers's ZBH Position: Q3 2019 in Review

Neuburgh Advisers reduced its Zimmer Biomet (ZBH) stake by 15% in Q3 2019, selling an estimated $126K and leaving 5,416 shares worth $722K. The position accounts for 0.02% of the portfolio, ranked #385.

Neuburgh Advisers first reported a position in ZBH in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.02M in Q1 2019. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

Neuburgh Advisers held 5,416 shares of Zimmer Biomet worth $722K as of Q3 2019.
Neuburgh Advisers sold 974 Zimmer Biomet shares in Q3 2019, an estimated $126K.
Zimmer Biomet made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #385 holding.
Neuburgh Advisers first reported a position in Zimmer Biomet in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Zimmer Biomet position peaked at $1.02M in Q1 2019.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.